Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-26

Clinical Trial Update: Assessment of HydroxyColl Bone Graft Substitute in High Tibial Osteotomy Wedge Grafting. [NA]

View source ↗

Summary

A clinical trial update evaluating the HydroxyColl Bone Graft Substitute for high tibial osteotomy wedge grafting in knee osteoarthritis. The current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HydroxyColl Bone Graft Substitute (hydroxyapatite-collagen bone graft substitute)

Snippet

Sponsor: SurgaColl Technologies Limited | Conditions: Osteoarthritis, Knee | NA | Status: UNKNOWN